Table 2

Adverse events (N=57).

Events	All grades, N (%)	Grade 3/4, N (%)
Hematologic
Anemia	48 (84.2)	24 (42.1)
Thrombocytopenia	22 (38.6)	10 (17.5)
Nonhematologic
Fatigue	6 (10.5)	0
Pneumonia	6 (10.5)	2 (3.5)
Elevated liver transaminases	6 (10.5)	0
Herpes zoster	2 (3.5)	0
Muscle spasms	2 (3.5)	1 (1.7)
Pulmonary embolism	2 (3.5)	1 (1.7)
Headache	1 (1.7)	0
Diarrhea	1 (1.7)	0
Urinary tract infection	1 (1.7)	0
Hepatitis B reactivation	1 (1.7)	0
Peripheral polyneuropathy	1 (1.7)	0
Cataract	1 (1.7)	0
Proteinuria	1 (1.7)	0
Creatinin elevated	1 (1.7)	0
Pancreas adenocarcinoma	1 (1.7)	0
Squamous cell carcinoma	1 (1.7)	0
Neuroendocrine tumor metastasis	1 (1.7)	0
Low grade dysplasia tubuler adenoma	1 (1.7)	0